Two Sigma Investments
BXRX

Two Sigma Investments’s Baudax Bio, Inc. Common Stock BXRX Stock Holding History

Two Sigma Investments’s Portfolio BXRX Stock Details BXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-163
Closed -$294K – 4771
2021
Q1 		$294K Buy
163
+72
+79% +$144K ﹤0.01% 3339
2020
Q4 		$128K Buy
+91
New +$186K ﹤0.01% 3187

Other funds holding BXRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Two Sigma Investments's BXRX Position: Q2 2021 in Review

Two Sigma Investments sold out of Baudax Bio, Inc. Common Stock (BXRX) in Q2 2021, closing a stake of 163 shares — an estimated $294K sold.

Two Sigma Investments first reported a position in BXRX in Q4 2020 and held it in 2 quarters. The position peaked at $294K in Q1 2021. 31 funds tracked by Wall St. Rank hold BXRX as of Q2 2021.

  • Two Sigma Investments reported no remaining Baudax Bio, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Two Sigma Investments sold 163 Baudax Bio, Inc. Common Stock shares in Q2 2021, an estimated $294K.
  • Two Sigma Investments first reported a position in Baudax Bio, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • Two Sigma Investments's Baudax Bio, Inc. Common Stock position peaked at $294K in Q1 2021.
  • 31 funds tracked by Wall St. Rank held Baudax Bio, Inc. Common Stock as of Q2 2021.

Based on Two Sigma Investments's 13F filing for Q2 2021, filed 16 Aug 2021.